This review explores the effects of reproductive aging on sexual function, emphasizing how hormonal changes during menopause impact sexual desire, arousal, and satisfaction. Common symptoms include vaginal dryness, dyspareunia, and reduced libido, which can significantly affect quality of life. The decline in estrogen levels leads to physiological changes that contribute
This cohort study analyzed the relationship between different formulations of menopausal hormone therapy (HT) and breast cancer risk, finding that estrogen-only therapies (both bioidentical and animal-derived) did not significantly increase breast cancer risk, while synthetic progestins were more strongly associated with an increased risk. The study highlights a 12% increased
This review examines the role of testosterone therapy in treating hypoactive sexual desire disorder (HSDD) in postmenopausal women, highlighting its potential to improve sexual desire, satisfaction, and frequency of satisfying sexual encounters. While some studies support its efficacy, results are not uniform across trials. Testosterone influences sexual desire by acting
This review article discusses the role of testosterone in treating hypoactive sexual desire disorder (HSDD) in postmenopausal women, particularly those who have undergone surgical menopause. Testosterone therapy (300 µg/day transdermally) was found to improve sexual desire and arousal with minimal side effects. However, the long-term risks of testosterone therapy remain
This randomized, double-blind, placebo-controlled trial evaluated the safety and efficacy of a transdermal testosterone patch for treating hypoactive sexual desire disorder (HSDD) in surgically menopausal women. Participants receiving testosterone therapy experienced a 67% increase in satisfying sexual activity compared to a 48% increase in the placebo group (p
This review explores the mental health challenges associated with menopause, particularly focusing on depression and memory problems. While menopausal women, especially those who are vulnerable, experience an increased risk of depression, hormone replacement therapy (HRT) does not show clear benefits for treating mental health symptoms. Antidepressants remain the primary treatment
This systematic review examined the safety of hormone replacement therapy (HRT) in BRCA1 and BRCA2 mutation carriers who have undergone risk-reducing salpingo-oophorectomy (RRSO). The findings indicate that short-term HRT does not increase breast cancer risk or reduce the protective effects of RRSO in women without a personal history of breast
This meta-analysis examined the effects of hormone replacement therapy (HRT) on components of metabolic syndrome in postmenopausal women. Results showed that HRT significantly reduced abdominal fat, insulin resistance, and new-onset diabetes, while improving cardiovascular health by reducing cholesterol ratios, blood pressure, and inflammatory markers. Oral HRT was more effective than
This retrospective cohort study assessed the impact of hormone replacement therapy (HRT) on survival outcomes in women under 50 treated for stage IB-IIB cervical adenocarcinoma. The study analyzed 58 patients divided into three groups: ovaries conserved (OVCON), iatrogenic menopause with HRT (IM-HRT), and iatrogenic menopause without HRT (IM-NOHRT). Five-year disease-specific
This study explores the relationship between nocturia and menopause, emphasizing how hormonal changes, particularly decreased estrogen and progesterone, contribute to increased nocturia symptoms in middle-aged women. The review highlights that other factors, such as obesity, diabetes, and hypertension, also play significant roles in worsening symptoms. Management strategies like hormone replacement
